New scalp elixir aims to thicken thinning hair

NCT ID NCT07271212

First seen Jun 26, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests a scalp elixir containing caffeine, panthenol, and growth factors on 60 healthy adults with hair thinning or baldness. Participants apply the product daily for 56 days, and researchers measure oil levels, hair density, thickness, length, and hair loss. The goal is to see if the elixir improves scalp and hair condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
caffeine, panthenol, insulin growth factor 1 (IGF-1), and fibroblast growth factor-7 (FGF-7) in a topical scalp elixir
What this could lead to
If it works, this could point toward a non-prescription scalp treatment to reduce hair thinning and improve hair density.
What could go wrong
This is a small, early-stage trial with only 60 participants and no blinding or placebo control for all groups. Results may not apply to everyone, and the effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hungkuang University

    Taichung, 433304, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.